Plant-based Vaccine Market is expected to reach US$ 108.9 Mn by 2028 growing at a CAGR of 23.8% over the Forecast Period


Plant-based Vaccine Market is expected to reach US$ 108.9 Mn by 2028 growing at a CAGR of 23.8% over the Forecast Period, Owing to Increasing Demand for Vaccines against Numerous Diseases, says Absolute Markets Insights

The healthcare sector has been lauded as a sector for the initiatives undertaken related to research and development. These initiatives have been observed to range from care procedures, products used to treat patients, medications, and operational processes, among others. The sector has also seen the expansion of medical disciplines leading to better care provision to patients through a number of approaches. These factors have been key in the growth of the curative care concept for healthcare. The concept of preventive care and comprehensive care has been observed to be growing in prominence primarily owing to the focus on reducing the dependence on medicine and channeling the efforts of recovery on the patients. This is expected to reduce the chances of side effects and instill a positive impact in the recovery phase for patients. Vaccines have been a key component in the healthcare sector with a growing prominence in the recent decade. These products are observed to be administered to users in order to provide them with immunity characteristics to specific diseases or disorders. The notable reason for the growth of vaccine adoption has been the rising incidences of diseases across numerous countries. In addition to this, the changes in terms of strains for certain disorders have led to an increasing demand for newer vaccination processes and products to be utilized. With advancements in vaccine development technologies, researchers have now focused on the creation of alternative sources for vaccine manufacturing and development. The utilization of plants as a base for vaccine production has been a relatively newer approach in the medical field and is seen to be picking pace in order to suffice the demand for innovative and optimized vaccines that help against numerous diseases. The adoption of plants as the bio-factories for immunoprotective antigens has been a key focus area in the research for plant based vaccines. These vaccines can be provided to users in the oral form or in the more traditional intramuscular administration methods. These factors have been instrumental in enhancing the demand for plant-based vaccine across a wide range of countries.

Request for Sample Copy of This Report@

The growing prevalence of the novel coronavirus had alerted the companies operating in the vaccine development business. Companies have integrated numerous internal teams and have utilized consulting services for enhancing their development capabilities in the process of getting to the optimal vaccine. The approach towards the adoption of plant bases for the vaccines has been observed to grow among certain enterprises. This has led to an influx of investments towards the plant-based vaccines market from numerous public and private organizations. These efforts are not only expected to help in curbing the threat of the novel coronavirus but are also expected to lead towards an enhancement for awareness regarding the concept and capabilities of plant-based vaccines on the global stage.

Enquiry Before Buying @

The detailed research study provides qualitative and quantitative analysis of plant-based vaccine market. The market has been analyzed from demand as well as supply side. The demand side analysis covers market revenue across regions and further across all the major countries. The supply side analysis covers the major market players and their regional and global presence and strategies. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

Key Findings of the Report:

  • The prevalence of numerous diseases has been observed to be on the rise over the years. The healthcare sector has been proactive in understanding the severity of these diseases/disorders and has invested towards vaccine development from time to time. The market has observed a steady influx in terms of investments from numerous organizations owing to demand for vaccines spanning a wide range of diseases and disorders. With the growth in the variety of disorders affecting human and animal life, the demand for various types of vaccines is bound to grow. Growing investments towards the development of plant-based vaccines is expected to strengthen the healthcare sector and help the reduction of potential cases related to a wide range of diseases.
  • In the efforts to develop vaccines against numerous disorders, research organizations and market participants have been studying the characteristics of various plants as potential sources. Notable plants used for the creation of vaccines include tobacco, potato, maize, nicotiana benthamiana (benth), and carrot cells, among others. The applicability of every source is being keenly studied for selecting the specific ingredients in order to provide users with the optimal care against potential health risks. Also, the initiatives for the development of plant based vaccines for animals are also creating improved source opportunities for the plants used in the market.
  • As far as geography is concerned, North America accounted for the maximum share in the global plant-based vaccine market for the recent year. The revenue share from the countries in the region has been observed to due to growing prevalence of medical research initiatives in the region. The region of Asia Pacific is expected to portray the fastest growth in terms of CAGR over the forecast period on the global scale. Increasing ventures from organizations in the region related to development of vaccines based on plant sources has been vital for the growth expectancy related to the market.
  • Some of the players operating in the plant-based vaccine market are Creative Biolabs, iBio, Inc., Medicago Inc., and Nomad Bioscience GmbH (Icon Genetics GmbH) amongst

Request for Customization@

Plant-based Vaccine Market:

  • By Clinical Trial
  • Phase I
  • Phase II
  • Others
  • By Type
  • Bacterial/ Agrobacterial vaccines
  • Transgenic
  • Viral Vaccines
  • Fungal Vaccines
  • Recombinant subunit vaccines
  • Parasitic Vaccines
  • Others
  • By Source
  • Tobacco, potato
  • Maize
  • Nicotiana benthamiana
  • Carrot cells, tobacco cells
  • Strawberry
  • Rice
  • Lettuce
  • Spinach
  • Others
  • By Disease Indication
  • Enterotoxigenic E. coli
  • Ebola virus
  • SUDV
  • Côte d’Ivoire ebolavirus
  • Bundibugyo ebolavirus
  • Norovirus
  • Hepatitis B virus
  • Rabies
  • Influenza
  • H1N1
  • H5N1
  • H7N9
  • Others
  • Cholera
  • Respiratory Syndromes
  • Cancer
  • Others
  • By Mode of Administration
  • Intramuscular
  • Oral Administration
  • Others
  • By End Users
  • Hospitals
  • Clinics
  • Primary Care Centers
  • Others
  • By Geography
  • North America
  • S
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
  • Denmark
  • Finland
  • Iceland
  • Sweden
  • Norway
  • Benelux Union
  • Belgium
  • The Netherlands
  • Luxembourg
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Southeast Asia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Rest of Southeast Asia
  • Rest of Asia Pacific
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

Get Full Information of this premium report@

About Us:

Absolute Markets Insights strives to be your main man in your business resolve by giving you insight into your products, market, marketing, competitors, and customers. Visit …

Contact Us:

Email id:

Contact Name: Shreyas Tanna

Phone: +91–740–024–2424